The 2026 Healthtech Messaging Index
Clairity
clairity.com·scored September 1, 2026
22/38
Invisible
The page is doing some work, but the story isn't landing fast enough. Buyers and AI are both left guessing what makes Clairity different.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for AI-powered breast cancer risk assessment software for mammography screening, it named:
Buyer we put in the prompt: Radiologist, breast imaging director, or VP of Clinical Services at a US health system or hospital network. Both the buyer and the category were inferred from Clairity’s homepage alone. The model had no web access.
Clairity was not on the list.
A buyer who asked AI this question got 8 names and moved on. Clairity never came up.
We asked AI who it recommends for "Radiologist, breast imaging director, or VP of Clinical Services at a US health system or hospital network" looking for "AI-powered breast cancer risk assessment software for mammography screening". It named iCAD, Hologic (Genius AI), Volpara Health, Lunit, Seno Medical. You did not appear. AI can't recommend what it can't clearly understand.
Overall assessment
Clairity's biggest strength is its hero sentence ... specific, mechanistic, and instantly quotable, with genuine founder authority from Harvard and FDA authorization that make it unmistakably distinct. The biggest gap is the complete absence of proof: no outcome numbers, no independent customer testimonials, no cost of inaction, and no conversion path ... a buyer who is convinced by the claim has nowhere to go and nothing to validate it with.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
07Cost of Inaction
“No mention of what happens if women or health systems do nothing ... no missed diagnoses, no late-stage catches, no cost of delay anywhere on the page.”
The page never names the price of inaction ... there are no stakes cited for women who skip risk assessment or health systems that don't adopt this tool.
All 19 signals, scored 0 to 2.
Total 22/38
Narrative Clarity
8 signals
- 2
01The 7-Second Test
“the first FDA-authorized AI platform that predicts a woman's five-year future risk of developing breast cancer, using only her existing screening mammogram”
Within seconds above the fold, a stranger knows exactly who this is for (women getting mammograms), what it does (predicts 5-year breast cancer risk), and how it works (existing mammogram only) ... clear enough for a caveat.
- 1
02Rebellion / Movement
“For more than 60 years, mammograms have saved lives by detecting early-stage cancers. Now, advancements in AI...can uncover hidden clues”
There's an implicit status-quo challenge (mammograms only detect, not predict), but no named enemy, no explicit rebellion statement ... the pushback is implied, not owned.
- 2
03Owned Language & Category
“Clairity Breast" and "the first FDA-authorized AI platform that predicts a woman's five-year future risk”
The branded product name 'Clairity Breast' and the specific 'five-year future risk' framing via mammogram are ownable, distinctive terms an AI could quote back to distinguish this from generic screening tools.
- 1
04ICP Clarity
“predicts a woman's five-year future risk of developing breast cancer" and the waitlist form asks "Are you a: Patient / Provider or Health System”
The page serves two audiences (patients and health systems) but doesn't clearly delineate what each gets ... a solo provider, hospital system, or radiology group can't instantly self-identify as the right buyer.
- 1
05Problem Leadership
“Peace of Mind Starts with Understanding Your Risk”
The headline gestures at a problem (anxiety about unknown risk) but leads with the emotional outcome rather than naming the concrete problem the buyer faces before they found Clairity.
- 2
06Solution Clarity
“predicts a woman's five-year future risk of developing breast cancer, using only her existing screening mammogram”
A visitor can repeat exactly what this company does in one sentence after reading the hero ... the mechanism, benefit, and input are all stated explicitly.
- 0
07Cost of Inactionweakest
“No mention of what happens if women or health systems do nothing ... no missed diagnoses, no late-stage catches, no cost of delay anywhere on the page.”
The page never names the price of inaction ... there are no stakes cited for women who skip risk assessment or health systems that don't adopt this tool.
- 1
08Promised Land
“help expand access to life-saving early detection and prevention for women everywhere”
The promised land is vague and generic ('women everywhere,' 'early detection') rather than a specific, vivid after-state for the actual buyer ... what does a woman's life or a health system's workflow look like after Clairity?
Trust Signal
4 signals
- 0
09Proof & Evidence
“No outcome numbers, before/after deltas, sensitivity stats, or clinical result figures anywhere on the homepage.”
Despite being an FDA-authorized clinical AI tool with published research, the homepage contains zero concrete performance numbers, accuracy rates, or patient outcome data.
- 1
10Social Proof
“Media logo bar labeled 'As Seen On' with outlets visible, and one named quote from Dr. Connie Lehman (who is also the founder).”
Media logos provide some credibility, but there are no customer testimonials with names and titles, no health system logos as clients, and the only quote is from the founder ... not an independent voice.
- 2
11Authority & Credibility
“Dr. Connie Lehman" described as "professor of radiology at Harvard Medical School" and "BCRF investigator" with published research in Radiology journal”
The founder's credentials are demonstrably strong ... Harvard professorship, peer-reviewed publication in a named journal, and named research foundation affiliation give this genuine authority.
- 0
12Alternatives Acknowledged
“No mention of competing risk models, BRCA testing, Tyrer-Cuzick, Gail model, or 'do nothing' as an alternative anywhere on the page.”
The page ignores every alternative a buyer might consider ... other AI tools, traditional risk models, or simply relying on standard annual mammograms ... making it harder for skeptical buyers to trust the positioning.
AI Signal
6 signals
- 1
13Customer Focus
“Peace of Mind Starts with Understanding Your Risk" vs. "we can help expand access to life-saving early detection”
The page mixes customer-facing language (peace of mind) with company-mission language (we can help expand access), tilting toward the company's vision rather than keeping the customer as consistent protagonist.
- 2
14AI-Parmesan Index
“advancements in AI and computer vision can uncover hidden clues in the mammograms ... invisible to the human eye”
The AI claim is mechanistic and specific ... computer vision analyzing existing mammogram images for invisible signals ... not a generic 'AI-powered' sprinkle, which earns full credit.
- 2
15LLM Quotability
“the first FDA-authorized AI platform that predicts a woman's five-year future risk of developing breast cancer, using only her existing screening mammogram”
This sentence is clean, declarative, factual, and specific enough that an LLM could lift it verbatim to describe or recommend Clairity Breast in a response about breast cancer risk AI tools.
- 2
16Copyright Freshness
“News items dated 2026/07, 2026/06, 2026/04 visible in image upload paths; copyright year appears current based on content freshness.”
Multiple recent content items with visible 2026 timestamps signal active content production that recency-sensitive AI engines will reward.
- 2
17Entity Distinctiveness
“first FDA-authorized AI platform that predicts a woman's five-year future risk...using only her existing screening mammogram”
The FDA-authorization claim, five-year prediction window, mammogram-only input, Harvard founder, and named product 'Clairity Breast' combine to make this unmistakably distinct from generic breast imaging AI competitors.
- 0
18AI Recommendation Check
“AI's picks: iCAD, Hologic (Genius AI), Volpara Health, Lunit, Seno Medical, DeepHealth. You were not named.”
We asked AI who it recommends for "Radiologist, breast imaging director, or VP of Clinical Services at a US health system or hospital network" looking for "AI-powered breast cancer risk assessment software for mammography screening". It named iCAD, Hologic (Genius AI), Volpara Health, Lunit, Seno Medical. You did not appear. AI can't recommend what it can't clearly understand.
Conversion Signal
1 signal
- 0
19Path & CTA Clarity
“Two CTAs exist ('Learn More' and 'Contact Us') but no numbered process, no explained steps, and no soft secondary CTA tied to a clear path to adoption.”
There is no visible process showing how a health system or patient adopts Clairity, and the two CTAs are parallel rather than primary/secondary ... buyers don't know what their next step actually is.
Your move
Think Clairity’s score is wrong? Good. Let’s look at it together.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Clairity the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.